Alexander Drilon and Sloan Kettering Cancer - Free people check

(1 - 20 from 20

)

Ignyta (NASDAQ:RXDX) - Ignyta Announces Alexander Drilon ...www.benzinga.com › news › ignyta-announces-alexander...

www.benzinga.com

Ignyta Announces Alexander Drilon, M.D. of Memorial Sloan Kettering Cancer Center, New York, New York, Presented Updated Results from ...

Memorial Sloan Kettering Cancer Center Oncologist in New York, NY...

www.wellness.com

Memorial Sloan Kettering Cancer Center is an Oncologist at York Avenue, New York, NY Wellness.com provides reviews, contact information, driving...

Alexander Drilon, Memorial Sloan Kettering Cancer Center - Internal...

doctor.webmd.com

Alexander Drilon is a practicing Internal Medicine doctor in New York, NY

Alexander Drilon | Memorial Sloan Kettering Cancer Center

www.mskcc.org

I am a medical oncologist who specializes in the treatment of lung cancer. I work with a team of experts including surgeons, radiation oncologists, pathologists, and ...

The Hamoui Foundation and LUNGevity Foundation Present ...

markets.businessinsider.com

· Alexander Drilon, MD, Associate Professor, Memorial Sloan Kettering Cancer Center; Identifying non-genomic mechanisms of RET TKI resistance. Many RET-positive cancers become resistant to targeted ...

Lung Cancer Research Foundation Awards $2.1 Million In Grants To...

www.prnewswire.com

Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center Targeting lung adenocarcinoma with MET exon 14 skipping mutations and ...

About Us - Elevation Oncology

elevationoncology.com

Dr. Alexander Drilon is the Acting Chief of the Early Drug Development Service and a medical oncologist on the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center in New York. His research focuses on the development of targeted therapy for genomic subsets of lung cancer and other solid tumors, ...

Pocket Oncology - Alexander Drilon, Michael Postow, Neil ...books.google.com › Medical › Oncology

books.google.de

Written and edited by leading cancer experts at Memorial Sloan Kettering Cancer Center, Pocket Oncology, Second Edition, is a practical, ...

Journal Credits | Nature Reviews Clinical Oncologywww.nature.com › ... › about the journal

www.nature.com

Heidelberg University, Germany. Alexander Drilon Memorial Sloan Kettering Cancer Center, USA. Terry J. Fry University of Colorado School of Medicine, USA.

Ignyta Announces Six Upcoming Presentations at the

www.1stoncology.com

Presenter: Alexander Drilon, M.D., Memorial Sloan Kettering Cancer Center Date/Time: Plenary Session 8: Exceptional Response and ...

The Hamoui Foundation and LUNGevity Foundation Present ...

finance.yahoo.com

· The award has been presented to: Alexander Drilon, MD, Associate Professor, Memorial Sloan Kettering Cancer Center. Identifying non-genomic mechanisms of RET TKI resistance. Many RET-positive ...

Alexander Drilon, MD - CMEducation Resources IQ&A ...www.iqanda-cme.com › flatDisplayPageSymposium

www.iqanda-cme.com

Alexander Drilon, MD. Alexander Drilon, MD. Medical Oncologist Memorial Sloan Kettering Cancer Center New York, NY, USA ...

Pocket Oncology eBook by Alexander Drilon Kobo.comwww.kobo.com › Kobo Books › eBooks › Nonfiction

www.kobo.com

Read "Pocket Oncology" by Alexander Drilon available from Rakuten Kobo. Written and edited by leading cancer experts at Memorial Sloan Kettering Cancer ...

Dr. Drilon on Entrectinib in Patients With Advanced Solid Tumors

www.onclive.com

Alexander Drilon, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses two studies investigating entrectinib in patients with advanced...

Targeting ROS1, RET, and BRAF in NSCLC | OncoTherapy Network

www.cancernetwork.com

Today, we are speaking with Dr. Alexander Drilon, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City who specializes in treating...

Dr. Drilon on NTRK Rearrangement in Lung Cancer

www.onclive.com

Alexander Drilon, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses NTRK rearrangement in patients with lung cancer.

Larotrectinib responses support routine NTRK gene fusion ...

www.mdedge.com

Although NTRK fusions are relatively infrequent in lung cancer, lead author Alexander Drilon, MD, of Memorial Sloan Kettering Cancer Center, ...

Dr. Drilon on Comprehensive Sequencing in Lung Cancerwww.onclive.com › onclive-tv › dr-drilon-on-compreh...

www.onclive.com

Alexander Drilon, MD, research director, Early Drug Development, Memorial Sloan Kettering Cancer Center, discusses performing ...

Ovid - Pocket Oncology | Wolters Kluwer

www.wolterskluwer.com

Written and edited by leading cancer experts at Memorial Sloan Kettering Cancer Center, Pocket Oncology, Second Edition, is a practical, high-yield reference...

Dr. Drilon on Results of the Phase I/II LIBRETTO-001 Trial

www.onclive.com

Alexander Drilon, MD, research director, Memorial Sloan Kettering Cancer Center, discusses the results of LIBRETTO-001, a phase I/II trial of RET inhibitor,...

All web results to the name "Alexander Drilon"

Related search requests for Alexander Drilon

Marc Ladanyi
Neil Vasan
Ophelia Manaog

People
Forename "Alexander" (53506)
Name "Drilon" (111)

sorted by relevance / date

Advanced Search

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Alexander Drilon and Sloan Kettering Cancer Free People Check